Table 2

Nonrandom additional cytogenetic aberrations in pediatric patients with −7 or del(7q)

Chromosomal aberrationCytogenetic subgroup
−7 otherdel(7q) other
Associated with del(7q)   
    t(8;21)(q22;q22) 
    t(15;17)(q22;q21) 
    inv(16)(p13q22) 10 
    t(9;11)(p22;q23) 
Associated with −7   
    inv(3)(q21q26)/t(3;3) 
    t(9;22)(q34;q11) 
    i(17q) 
    + 21 
Associated with −7 and del(7q)   
    −5/5q– 
    + 8 
    der(11q) 
    del(12p) 
    t(8;16)(p11;p13) 
Chromosomal aberrationCytogenetic subgroup
−7 otherdel(7q) other
Associated with del(7q)   
    t(8;21)(q22;q22) 
    t(15;17)(q22;q21) 
    inv(16)(p13q22) 10 
    t(9;11)(p22;q23) 
Associated with −7   
    inv(3)(q21q26)/t(3;3) 
    t(9;22)(q34;q11) 
    i(17q) 
    + 21 
Associated with −7 and del(7q)   
    −5/5q– 
    + 8 
    der(11q) 
    del(12p) 
    t(8;16)(p11;p13) 

For the −7 other group, n = 51; for the del(7q) other group, n = 46. The aberrations are grouped according to whether they were predominately associated with del(7q), −7, or both. Other aberrations considered as random were observed in 31 patients with −7 and in 19 patients with del(7q).

Close Modal

or Create an Account

Close Modal
Close Modal